Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT07822178

Neural Mechanisms of Social Attribution From Faces

The purpose of this study is to examine how the brain processes faces, which are some of the most important stimuli that we view, process, and make decisions about as we go through daily life. This project examines the dynamics of where and when in the brain information conveyed by faces is represented, how such information is modulated by context and goals, and how such information is used to make decisions about faces.

Enrolling by invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cedars-Sinai Medical Center, Los Angeles, California, United States

Loading trial locations.

About this study

Despite the importance of faces for decision making, little is known about the neural mechanisms of how information conveyed by faces is extracted and used to inform decisions we make. The goal of this research is to develop a circuit-level understanding of face processing. As part of this study, investigators will conduct experiments that utilize the rare opportunity to record in-vivo from human single neurons simultaneously in multiple brain areas in patients undergoing treatment for drug resistant epilepsy.

Researchers will investigate three overarching hypotheses on the neural substrate of face processing. Aim 1: To determine the fast temporal dynamics of face processing. Aim 2: To modulate face-related neural activity with Contextual Information. Aim 3: To test the causal relevance of face-related neural activity.

The expected outcomes of this work are a characterization of how neural representations of faces are formed, how they enable making decisions about faces, and how the face-related neural activity is modulated by context.

Participants in this study are patients undergoing invasive monitoring for suspected focal epilepsy with depth electrodes. Subjects will conduct a variety of cognitive tests on a computer placed in front of them during their hospital stay. Participating hospitals in this study are Cedars-Sinai and Stanford Hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Intractable epilepsy, undergoing invasive monitoring
  • Age ≥18
  • Full Scale Intelligence Quotient > 70
  • Ability to comprehend and perform simple behavioral tasks by pressing buttons on laptop computer in response to questions.

Exclusion criteria

  • Determination by clinicians and investigators that a patient is unable to complete the behavioral tasks required for the protocol due to either cognitive limits, psychological limits, or pain.

Treatment and study plan

Cedrus RB-844 response pad; Adtech Behnke-Fried micro-electrodes; Neurolynx electrophysiology system; Blackrock Cerestim stimulator

Behavioral

Devices listed are components of a single intervention that includes: Record patient responses (Cedrus RB-844), record neuronal activity (Neurolynx) from electrodes (Adtech Behnke-Fried), apply intermittent electrical stimulation (Blackrock Cerestim)

Primary outcomes

  1. Neuronal population activity

    Time frame: 5 years

    Proportion of experiment sessions in which representations of decision-related aspects of faces emerged in subjects that successfully performed the task

  2. Contextual modulation

    Time frame: 5 years

    Percentage of neurons that carry face-related information whose activity was modulated by context.

  3. Effect of electrical stimulation

    Time frame: 5 years

    Proportion of experiment sessions in which electrical stimulation modulated face-based decision making.

Sponsors and collaborators

Lead sponsor

Cedars-Sinai Medical Center

Other

Collaborators

  • California Institute of Technology
  • National Institute of Mental Health (NIMH)
  • Stanford University

Registry information

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Sep 16, 2026
Registry last updated
Sep 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.